Apyx Medical Corporation APYX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Oem | $1.76M+13.8% | $2.45M+15.6% | $1.81M-17.6% | $1.7M-28.5% | $1.54M-44.7% | |
| Surgical Aesthetics | $10.73M+36.1% | —— | $11.07M+19.1% | —— | $7.89M— | |
| Other Operating Income Expense Net by Business | ||||||
| Oem | $0— | $0— | $0— | —— | —— | |
| Surgical Aesthetics | $0— | —— | $0— | —— | —— | |
| Gross Profit by Business | ||||||
| Oem | $451K+360% | $915K+122% | $670K+75.4% | $185K-59.9% | $98K-87.1% | |
| Surgical Aesthetics | $7.47M+34.3% | —— | $7.63M+16.1% | —— | $5.57M— | |
| Profit Loss by Business | ||||||
| Oem | $443K+382% | $915K+125% | $667K+78.8% | $181K-60.7% | $92K-87.4% | |
| Surgical Aesthetics | $1.99M+13,133% | —— | $1.9M+504% | —— | $15K— | |
| Operating Income by Business | ||||||
| Oem | $443K+382% | $915K+125% | $667K+78.8% | $181K-60.7% | $92K-87.4% | |
| Surgical Aesthetics | $1.99M+13,133% | —— | $1.9M+504% | —— | $15K— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||||
| Oem | $443K+382% | $915K+125% | $667K+78.8% | $181K-60.7% | $92K-87.4% | |
| Surgical Aesthetics | $1.99M+13,133% | —— | $1.9M+504% | —— | $15K— | |
| Income Tax Expense Benefit by Business | ||||||
| Oem | $0— | $0— | $0— | $0— | $0— | |
| Surgical Aesthetics | $0— | —— | $0— | —— | $0— | |
| Interest Expense Nonoperating by Business | ||||||
| Oem | -$0— | $0— | -$0— | -$0— | -$0— | |
| Surgical Aesthetics | -$0— | —— | -$0— | —— | -$0— | |
| Cost of Goods Sold by Business | ||||||
| Oem | $1.31M-9.7% | $1.54M-10.1% | $1.14M-37.1% | $1.52M-21.0% | $1.45M-28.9% | |
| Surgical Aesthetics | $3.26M+40.5% | —— | $3.44M+26.6% | —— | $2.32M— | |
| Investment Income Interest by Business | ||||||
| Oem | $0— | $0— | $0— | $0— | $0— | |
| Surgical Aesthetics | $0— | —— | $0— | —— | $0— | |
| Other Expenses by Business | ||||||
| Oem | $8K+33.3% | $0-100% | $3K-66.7% | $4K— | $6K-76.9% | |
| Surgical Aesthetics | $4.42M-6.2% | —— | $4.48M-24.2% | —— | $4.71M— | |
| Sales Commissions And Fees by Business | ||||||
| Oem | $0— | $0— | $0— | $0— | $0— | |
| Surgical Aesthetics | $1.07M+27.1% | —— | $1.26M+10.9% | —— | $839K— | |
| Revenue by Geography | ||||||
| Non Us | $4.38M+62.9% | $4.21M+15.2% | $3.55M-4.0% | $3.6M+3.9% | $2.69M-17.7% | |
| US | $8.11M+20.3% | $14.95M+41.5% | $9.33M+19.7% | $7.78M-10.5% | $6.74M-3.4% | |
| Non-Current Assets by Geography | ||||||
| Non Us | $916K-17.3% | $1M-16.8% | $1.06M— | $1.03M— | $1.11M— | |
| US | $5.43M+0.1% | $5.61M+1.5% | $5.7M— | $5.52M— | $5.43M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Apyx Medical Corporation break its business down?
- Apyx Medical Corporation (APYX) reports revenue by business across 2 parts — Oem and Surgical Aesthetics. Each is extracted from the segment footnotes and tracked over time.
- Where does Apyx Medical Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Apyx Medical Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
